GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
2,759
Funds Holding Change
-12
Funds Holding Growth
-0.4%
Value
$527B
Holding in Top 10
435
Top 10 Change
-20
Top 10 Growth
-4%
Value Growth
+2%
New
92
Increased
1,111
Reduced
1,320
Closed
80
Capital Inflow
$18.6B
Capital Outflow
$14B
Net Capital Flow
+$4.59B
Capital Flow Change
-$3.35B
Calls
$5.97B
Puts
$7.45B
Net Calls
-$1.48B
Put/Call Ratio
1.25